Prognostic-disability Biomarkers in Multiple Sclerosis: Review of the Literature from the Last Five Years/Multipl Skleroz Olgularinda Prognoz-Ozurluluk Biyoisaretcileri: Son Bes Yila Ait Literaturun Gozden Gecirilmesi

With the advent of new agents in the treatment of multiple sclerosis, new treatment modalities have emerged (escalation-induction therapy) and the increased efficacy of the drugs has led to increased drug-related risks. The risk/benefit balance has become more carefully assessed. The increased need...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Türk nöroloji dergisi 2018-09, Vol.24 (3), p.203
1. Verfasser: Kiylioglu, Nefati
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 3
container_start_page 203
container_title Türk nöroloji dergisi
container_volume 24
creator Kiylioglu, Nefati
description With the advent of new agents in the treatment of multiple sclerosis, new treatment modalities have emerged (escalation-induction therapy) and the increased efficacy of the drugs has led to increased drug-related risks. The risk/benefit balance has become more carefully assessed. The increased need for reliable markers to predict prognosis-disability has also led to an increase in research conducted in this area. In this short review, studies published between 2012-2017, especially those related to prognosis and disability, were compiled. Keywords: Multiple sclerosis, disability, prognosis, biomarker Multipl skleroz hastaligi tedavisine yeni ajanlarin girmesi ile yeni tedavi modelleri olusmus (basamakli tedavi-indüksiyon tedavisi) ve ilaçlarin artan etkinligi beraberinde ilaç ile iliskili artan riskleri de tasimistir. Risk/yarar dengesi daha dikkatle degerlendirilir hale gelmistir. Prognozu-özürlülügü tahmin ettiren güvenilir isaretçilere artan gereksinim ile bu alanda yapilan arastirmalar da artma göstermistir. Bu kisa gözden geçirme çalismasinda 2012-2017 yillari arasinda yapilmis yayinlarda özellikle prognoz ve özürlülük ile iliskili olanlar derlenmistir. Anahtar Kelimeler: Multipl skleroz, özürlülük, prognoz, biyoisaretçi
doi_str_mv 10.4274/tnd.79836
format Article
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A559524678</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A559524678</galeid><sourcerecordid>A559524678</sourcerecordid><originalsourceid>FETCH-LOGICAL-g678-30691e317f97334f0538231d488a7b925a60ba5d17e2328d91e551cc6cbbf98d3</originalsourceid><addsrcrecordid>eNptj8tOwzAQRbMAiap0wR-MxDolifPsrq14SUVFlAWsKseelKFOjGwHRP-Uv8GolWDBzGKk0Zl77wTBWRyN06RIL1wnx0VVsvwoGMQsisMoT55OgpG1r5EvVhVVzgbB173Rm05bRyKUZHlNitwnzEi33GzRWKAO7nrl6E0hrIRCoy3ZCTzgO-EH6AbcC8KCHBrueoPQGN3ud9w6uKJ3hGfkxl4cVGC1_RHZwVJtesUNdZLDPsUuXO56o3rVb32CT-3zGHSCPE8TWOkOZmjhmRSHKblf076Da72T6AcKMqRatHQaHDdcWRwd5jB4vLp8nN-Ei-X17Xy6CDd5UYYsyqsYWVw0VcFY2kQZKxMWy7QseVFXScbzqOaZjAtMWFJKD2dZLEQu6rqpSsmGwfledsMVrqlrtDNctGTFepplVZak3sZT438o3xJbErrDxj_59-AbHcORSg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Prognostic-disability Biomarkers in Multiple Sclerosis: Review of the Literature from the Last Five Years/Multipl Skleroz Olgularinda Prognoz-Ozurluluk Biyoisaretcileri: Son Bes Yila Ait Literaturun Gozden Gecirilmesi</title><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Kiylioglu, Nefati</creator><creatorcontrib>Kiylioglu, Nefati</creatorcontrib><description>With the advent of new agents in the treatment of multiple sclerosis, new treatment modalities have emerged (escalation-induction therapy) and the increased efficacy of the drugs has led to increased drug-related risks. The risk/benefit balance has become more carefully assessed. The increased need for reliable markers to predict prognosis-disability has also led to an increase in research conducted in this area. In this short review, studies published between 2012-2017, especially those related to prognosis and disability, were compiled. Keywords: Multiple sclerosis, disability, prognosis, biomarker Multipl skleroz hastaligi tedavisine yeni ajanlarin girmesi ile yeni tedavi modelleri olusmus (basamakli tedavi-indüksiyon tedavisi) ve ilaçlarin artan etkinligi beraberinde ilaç ile iliskili artan riskleri de tasimistir. Risk/yarar dengesi daha dikkatle degerlendirilir hale gelmistir. Prognozu-özürlülügü tahmin ettiren güvenilir isaretçilere artan gereksinim ile bu alanda yapilan arastirmalar da artma göstermistir. Bu kisa gözden geçirme çalismasinda 2012-2017 yillari arasinda yapilmis yayinlarda özellikle prognoz ve özürlülük ile iliskili olanlar derlenmistir. Anahtar Kelimeler: Multipl skleroz, özürlülük, prognoz, biyoisaretçi</description><identifier>ISSN: 1301-062X</identifier><identifier>DOI: 10.4274/tnd.79836</identifier><language>eng</language><publisher>Galenos Yayinevi Tic. Ltd</publisher><subject>Biological markers ; Care and treatment ; Disabilities ; Multiple sclerosis ; Prognosis ; Risk factors</subject><ispartof>Türk nöroloji dergisi, 2018-09, Vol.24 (3), p.203</ispartof><rights>COPYRIGHT 2018 Galenos Yayinevi Tic. Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,27924,27925</link.rule.ids></links><search><creatorcontrib>Kiylioglu, Nefati</creatorcontrib><title>Prognostic-disability Biomarkers in Multiple Sclerosis: Review of the Literature from the Last Five Years/Multipl Skleroz Olgularinda Prognoz-Ozurluluk Biyoisaretcileri: Son Bes Yila Ait Literaturun Gozden Gecirilmesi</title><title>Türk nöroloji dergisi</title><description>With the advent of new agents in the treatment of multiple sclerosis, new treatment modalities have emerged (escalation-induction therapy) and the increased efficacy of the drugs has led to increased drug-related risks. The risk/benefit balance has become more carefully assessed. The increased need for reliable markers to predict prognosis-disability has also led to an increase in research conducted in this area. In this short review, studies published between 2012-2017, especially those related to prognosis and disability, were compiled. Keywords: Multiple sclerosis, disability, prognosis, biomarker Multipl skleroz hastaligi tedavisine yeni ajanlarin girmesi ile yeni tedavi modelleri olusmus (basamakli tedavi-indüksiyon tedavisi) ve ilaçlarin artan etkinligi beraberinde ilaç ile iliskili artan riskleri de tasimistir. Risk/yarar dengesi daha dikkatle degerlendirilir hale gelmistir. Prognozu-özürlülügü tahmin ettiren güvenilir isaretçilere artan gereksinim ile bu alanda yapilan arastirmalar da artma göstermistir. Bu kisa gözden geçirme çalismasinda 2012-2017 yillari arasinda yapilmis yayinlarda özellikle prognoz ve özürlülük ile iliskili olanlar derlenmistir. Anahtar Kelimeler: Multipl skleroz, özürlülük, prognoz, biyoisaretçi</description><subject>Biological markers</subject><subject>Care and treatment</subject><subject>Disabilities</subject><subject>Multiple sclerosis</subject><subject>Prognosis</subject><subject>Risk factors</subject><issn>1301-062X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNptj8tOwzAQRbMAiap0wR-MxDolifPsrq14SUVFlAWsKseelKFOjGwHRP-Uv8GolWDBzGKk0Zl77wTBWRyN06RIL1wnx0VVsvwoGMQsisMoT55OgpG1r5EvVhVVzgbB173Rm05bRyKUZHlNitwnzEi33GzRWKAO7nrl6E0hrIRCoy3ZCTzgO-EH6AbcC8KCHBrueoPQGN3ud9w6uKJ3hGfkxl4cVGC1_RHZwVJtesUNdZLDPsUuXO56o3rVb32CT-3zGHSCPE8TWOkOZmjhmRSHKblf076Da72T6AcKMqRatHQaHDdcWRwd5jB4vLp8nN-Ei-X17Xy6CDd5UYYsyqsYWVw0VcFY2kQZKxMWy7QseVFXScbzqOaZjAtMWFJKD2dZLEQu6rqpSsmGwfledsMVrqlrtDNctGTFepplVZak3sZT438o3xJbErrDxj_59-AbHcORSg</recordid><startdate>20180901</startdate><enddate>20180901</enddate><creator>Kiylioglu, Nefati</creator><general>Galenos Yayinevi Tic. Ltd</general><scope/></search><sort><creationdate>20180901</creationdate><title>Prognostic-disability Biomarkers in Multiple Sclerosis: Review of the Literature from the Last Five Years/Multipl Skleroz Olgularinda Prognoz-Ozurluluk Biyoisaretcileri: Son Bes Yila Ait Literaturun Gozden Gecirilmesi</title><author>Kiylioglu, Nefati</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g678-30691e317f97334f0538231d488a7b925a60ba5d17e2328d91e551cc6cbbf98d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Biological markers</topic><topic>Care and treatment</topic><topic>Disabilities</topic><topic>Multiple sclerosis</topic><topic>Prognosis</topic><topic>Risk factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kiylioglu, Nefati</creatorcontrib><jtitle>Türk nöroloji dergisi</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kiylioglu, Nefati</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prognostic-disability Biomarkers in Multiple Sclerosis: Review of the Literature from the Last Five Years/Multipl Skleroz Olgularinda Prognoz-Ozurluluk Biyoisaretcileri: Son Bes Yila Ait Literaturun Gozden Gecirilmesi</atitle><jtitle>Türk nöroloji dergisi</jtitle><date>2018-09-01</date><risdate>2018</risdate><volume>24</volume><issue>3</issue><spage>203</spage><pages>203-</pages><issn>1301-062X</issn><abstract>With the advent of new agents in the treatment of multiple sclerosis, new treatment modalities have emerged (escalation-induction therapy) and the increased efficacy of the drugs has led to increased drug-related risks. The risk/benefit balance has become more carefully assessed. The increased need for reliable markers to predict prognosis-disability has also led to an increase in research conducted in this area. In this short review, studies published between 2012-2017, especially those related to prognosis and disability, were compiled. Keywords: Multiple sclerosis, disability, prognosis, biomarker Multipl skleroz hastaligi tedavisine yeni ajanlarin girmesi ile yeni tedavi modelleri olusmus (basamakli tedavi-indüksiyon tedavisi) ve ilaçlarin artan etkinligi beraberinde ilaç ile iliskili artan riskleri de tasimistir. Risk/yarar dengesi daha dikkatle degerlendirilir hale gelmistir. Prognozu-özürlülügü tahmin ettiren güvenilir isaretçilere artan gereksinim ile bu alanda yapilan arastirmalar da artma göstermistir. Bu kisa gözden geçirme çalismasinda 2012-2017 yillari arasinda yapilmis yayinlarda özellikle prognoz ve özürlülük ile iliskili olanlar derlenmistir. Anahtar Kelimeler: Multipl skleroz, özürlülük, prognoz, biyoisaretçi</abstract><pub>Galenos Yayinevi Tic. Ltd</pub><doi>10.4274/tnd.79836</doi></addata></record>
fulltext fulltext
identifier ISSN: 1301-062X
ispartof Türk nöroloji dergisi, 2018-09, Vol.24 (3), p.203
issn 1301-062X
language eng
recordid cdi_gale_infotracmisc_A559524678
source DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals
subjects Biological markers
Care and treatment
Disabilities
Multiple sclerosis
Prognosis
Risk factors
title Prognostic-disability Biomarkers in Multiple Sclerosis: Review of the Literature from the Last Five Years/Multipl Skleroz Olgularinda Prognoz-Ozurluluk Biyoisaretcileri: Son Bes Yila Ait Literaturun Gozden Gecirilmesi
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T16%3A06%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prognostic-disability%20Biomarkers%20in%20Multiple%20Sclerosis:%20Review%20of%20the%20Literature%20from%20the%20Last%20Five%20Years/Multipl%20Skleroz%20Olgularinda%20Prognoz-Ozurluluk%20Biyoisaretcileri:%20Son%20Bes%20Yila%20Ait%20Literaturun%20Gozden%20Gecirilmesi&rft.jtitle=T%C3%BCrk%20n%C3%B6roloji%20dergisi&rft.au=Kiylioglu,%20Nefati&rft.date=2018-09-01&rft.volume=24&rft.issue=3&rft.spage=203&rft.pages=203-&rft.issn=1301-062X&rft_id=info:doi/10.4274/tnd.79836&rft_dat=%3Cgale%3EA559524678%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A559524678&rfr_iscdi=true